Earlier this year, Cellular Goods, a cannabis skincare company backed by David Beckham, became just the third cannabis company to list on the London Stock Exchange (LSE).
Earlier this week, the company finally launched its first product line, cannabigerol (CBG)-infused serum, face oil and aftershave moisturizer.
CBG, also known as the “mother cannabinoid,” contains potent antimicrobial and anti-inflammatory properties. A study out of McMaster University last year found the cannabinoid was capable of killing the superbug methicillin-resistant Staphylococcus aureus (MRSA).
The CBG not only destroyed the MRSA microbes, but also prevented the bacteria from forming “biofilms,” communities of microorganisms that attach to surfaces and allow them to spread.
According to the Evening Standard, Cellular Goods is now preparing a marketing push for early 2022.
In June, the company partnered with Vancouver-based Willow Biosciences Inc., a biotech company that develops and produces plant-derived
Read full article on The Growth Op
